EDS Accelerator Award
EDS Accelerator Award supports independent investigators with funding for technology validation and de-risking of ongoing cancer research to advance their projects toward commercialization.
Browse similar grants
Funder: American Cancer Society
Due Dates: Rolling (submissions) | 60 days after application creation (ProposalCentral deadline)
Funding Amounts: $75,000 in direct costs for one year; indirect costs are not allowed
Summary: Supports commercialization of ongoing cancer research through technology validation and de-risking.
Key Information: Independent investigators at any career stage may apply through eligible nonprofit institutions in the United States or its territories.
Description
The American Cancer Society’s EDS Accelerator Award supports commercialization of an ongoing cancer research project. Its focus is technology validation and de-risking: funding work that advances research already underway toward commercialization, rather than a broader program of new research projects. Independent investigators at any career stage may apply.
The award is managed by the Society’s Extramural Discovery Science (EDS) team. ACS supports basic, translational, clinical, and cancer control research as its financial resources allow. Within that wider research commitment, this award provides focused, one-year support for the commercialization-related stage of a cancer research project.
